Posted by Michael Wonder on 11 Sep 2017
Iron infusions in the community
11 September 2017 - Eligible people will now be able to receive ferric carboxymaltose iron infusions in some general practitioners’ clinics or other community based settings.
PHARMAC is pleased to inform you about our decision to list ferric carboxymaltose (Ferinject) 50 mg per ml, 10 ml vial in Section B (Community) of the Pharmaceutical Schedule.
Patients will need to meet the Special Authority criteria to be eligible to receive the funded medicine.
